Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zixue San is a traditional Chinese medicine (TCM) formula produced by Tianjin Hong Ren Tang Pharmaceutical, categorized as a heat-clearing and wind-extinguishing medication. It is historically recognized as one of the "Three Treasures of Cooling" (凉开三宝) in TCM, used to treat critical conditions involving high fever and neurological impairment. The formula is indicated for high fever, convulsions, delirium, and loss of consciousness, often associated with severe infections or "heat entering the pericardium" in TCM theory. It works by clearing internal heat, detoxifying the body, and calming the spirit. The preparation is typically a reddish-brown to grayish-brown powder with a fragrant odor and a cool, slightly bitter taste. Modern formulations are standardized to ensure safety and efficacy while often substituting endangered animal components with sustainable alternatives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zixue san.